Giants “have to sit down and talk about” Barry Zito’s future


San Francisco still owes Barry Zito $19 million next season, $20 million in 2013, and a $7 million buyout in 2014, but when asked yesterday about the left-hander’s future role with the Giants manager Bruce Bochy replied: “We’ll have to sit down and talk about it … I can’t answer that.”

Zito has been one of the biggest free agent busts in baseball history, at no point living up to his $126 million contract, but when healthy he’s at least been a decent back-of-the-rotation starter with a 4.52 ERA in 818 innings for the Giants.

However, this season he has a 5.62 ERA in nine starts and has spent much of the year on the disabled list. And the Giants’ impressive collection of young starting pitching means they may not really need a decent back-of-the-rotation starter in 2012 and beyond.

As it stands now the Giants figure to enter next season with Tim Lincecum, Matt Cain, Madison Bumgarner, and Ryan Vogelsong locked into the rotation, leaving Zito to potentially compete for the final spot with Eric Surkamp and Jonathan Sanchez. San Francisco has been in a contract-eating, veteran-releasing mood lately, cutting Aaron Rowand and Miguel Tejada, but so far Zito has avoided the ax.

Jorge Polanco suspended 80 games after testing positive for Stanozolol

Brian Blanco/Getty Images
Leave a comment’s Rhett Bollinger reports that Twins shortstop Jorge Polanco has been suspended 80 games after testing positive for the performance-enhancing drug Stanozolol.

In a statement, via Dan Hayes of The Athletic, Polanco denied knowingly using the substance. Polanco said, “To be clear, I did not intentionally consume this steroid. I now know, however, that my intention alone is not a good enough excuse and I will pay the price for my error in judgment. The substance that I requested from my athletic trainer in the Dominican Republic and consented to take was a combination of vitamin B12 and an iron supplement, something that is not unusual or illegal for professional athletes to take. Unfortunately, what I was given was not that supplement and I take full responsibility for what is in my body.”

Last year was Polanco’s first full season in the majors. He hit .256/.313/.410 with 13 home runs, 74 RBI, 60 runs scored, and 13 stolen bases in 544 plate appearances.

The Twins have Ehire Adrianza and Erick Aybar to handle shortstop while Polanco is out. The club could also give the starting job to prospect Nick Gordon, ranked No. 4 in the Twins’ system according to MLB Pipeline. Gordon had a solid 2017 campaign at Double-A Chattanooga, posting a .749 OPS with 29 doubles and 13 steals in 578 PA.